WellTheory
Founded in 2021 in the United States, WellTheory uses AI to match autoimmune disease patients with treatment plans.
About
Founded in 2021 in the United States, WellTheory uses AI to match autoimmune disease patients with treatment plans. Its Care Scribe and Care Hub tools help care teams transcribe consultations and coordinate patient care.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Company· 12
Investor· 6
Founders / team· 1
Funding history
- 2025-05New funding round$5M
Investors · Samsung Next, Up2 Fund, Accel, OVO Fund, Opal Ventures, BoxGroupSource · SVTR Weekly #106
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- WellTheory
Uses AI to match autoimmune disease patients with treatment options and provide support
Undisclosed · $5M · 2025-05
$5M
United States
BusinessLatest roundTotal raisedDate- Mirae
Conversational AI that turns autoimmune patients' daily symptoms between visits into structured longitudinal records to support clinician decisions
Seed · $5M · 2026-07
$5M - Ascertain
AI that automates prior authorization, documentation and patient communication for healthcare providers
Series A · $10M · 2025-04
$10M - Bonsai Health
AI that automates medical front-office workflows and drives patient follow-up
Seed · $7M · 2025-09
$7M
China
BusinessLatest roundTotal raisedDate- 格式塔科技
Ultrasound brain-computer interface for whole-brain read/write, treating chronic pain, stroke rehabilitation, PTSD and other neurological conditions
Angel · $80M · 2026-07
$80M - Renerval Biotherapeutics
iPSC-based artificial blood (regenerated platelets/red blood cells) and off-the-shelf cell therapies: R&D and scaled manufacturing
Series A · $21M · 2026-08
$21M
Europe
BusinessLatest roundTotal raisedDate- BuddyRise
AI health companion app for autoimmune disease patients (B2C): symptom tracking + trigger identification + personalized recommendations + visit reports.
— - Flok Health
AI-run physical therapy that diagnoses, triages, treats and discharges musculoskeletal patients for health systems via mobile consultations
Series A · $13M · 2026-06
$13M - ReportAId
AI that interprets and extracts medical report data to help providers improve patient care, engagement and retention
Pre-Seed · $3M · 2025-05
$3M
Other / unspecified
BusinessLatest roundTotal raisedDate- AssistIQ
Uses AI to help hospitals track surgical supplies to reduce costs
Series A · $12M · 2025-05
$12M - Reliant AI
Uses generative AI to help biopharma companies organize and analyze data for clinical trials or scientific publications
Seed · $11M · 2024-08
$11M - Even Healthcare
Health subscription membership for individuals and businesses (unlimited consultations, free testing), with a company-operated network of hospitals and clinics and accompanying health insurance.
Series B · $120M · 2026-10 · Valuation $300M
$120MValuation $300M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.